Home Companies WWHS Biotech.Inc(exclusive marketed by Dawin)

TT4 One-Step Thyroxine Rapid Quantitative Test Kit Fluorescence Immunoassay

WWHS Biotech.Inc(exclusive marketed by Dawin)

Contact Us

[China] country

Trade Verify

Address: Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen

Contact name:Richard

Inquir Now

WWHS Biotech.Inc(exclusive marketed by Dawin)

Verified Suppliers
  • Trust
    Seal
  • Verified
    Supplier
  • Credit
    Check
  • Capability
    Assessment

TT4 One-Step Thyroxine Rapid Quantitative Test Kit Fluorescence Immunoassay

Country/Region china
City & Province shenzhen
Categories Examination & Testing Instrument
InquireNow

Product Details

【Product name】 TT4.pdf

Total Thyroxine(TT4)Rapid Quantitative Test(Fluorescence immunoassay)

 

【Test principle】

The TT4 Rapid Test is a one-step chromatographic sandwich immunoassay designed for the quantitative measurement of TT4. The T4 antigen in the sample was first bound with the conjugated compound of fluorescent labeled T4 monoclonal antibody, then moved and combined with another T4 monoclonal antibody fixed on the nitrocellulose membrane, and the double antibody sandwich complex was formed at the detection line of the cellulose nitrate membrane. The quantitative detection results were obtained by NIR-1000 dry fluoroimmunoassay analyser.

 

【Components】

NameQuantityComponent
Test cards25It is composed of fluorescent pad (coated with fluorescent labeled T4 monoclonal mouse antibody), nitrocellulose membrane (coated with T4 monoclonal mouse antibody and Goat anti mouse IgG antibody), absorbent paper and backing
Sample diluent25(200μL/tube)Phosphate buffer
ID card1With specific stand curve file
 

The components in different batches of kits cannot be used interchangeably.

 

【Sample requirements】

  1. Plasma, serum and whole blood can be used as samples. The whole blood should be collected in a tube containing heparin, citrate or EDTA as the anticoagulant. If the serum procedure is used, collect blood in a tube without anticoagulant and allow clotting. Hemolyzed samples should not be used.
  2. Venous blood was collected according to routine laboratory methods to avoid hemolysis.
  3. It is highly recommended to use fresh samples instead of keeping the samples at room temperature for a long time. After samples were collected, the detection should be completed within 4 hours at room temperature (15℃~30℃). The whole blood sample can be stored at 2℃~8℃ for 24 hours. Plasma and serum samples can be stored at 2℃~ 8℃ for 7 days, -20℃for 30 days.
  4. Before testing, the sample should return to room temperature (15℃~30℃). The frozen samples should be completely thawed, rewarming and mixed evenly before use. Repeated freeze-thaw cycles should be avoided.

 

【Test procedure】

  1. Before the test, please read the instructions completely. If the test card and sample are stored in cold storage, they should be balanced at room temperature (15-30)℃ for not less than 30min before use.
  2. Start NIR-1000 dry fluoroimmunoassay analyser and correctly select the corresponding sample type on the instrument.
  3. Take out the ID card, make sure that the batch number of the ID card is consistent with that of the test card, and insert the ID card into the ID card port of the instrument.
  4. Take out the test card from the aluminum foil bag and use it within 15 minutes.
  5. Place the test card on a clean horizontal table and mark it horizontally.
  6. Mix 100 µL of patient sample with 200µL of sample diluent. Apply 100 µL of diluted samples to the well of the test card.
  7. At 15 minutes after addition of samples, insert the test card into NIR-1000 dry fluoroimmunoassay analyser and click the “Instant test” button to read the results.

【Performance】

1. Limits of detection

No higher than 5.0nmoL/L.

2. Accuracy

The relative deviation from the target value is within ±15%.

3. Precision

The within and between assay coefficient of variations are within 15%.

4. Linear range

Within the linear range (5.0 ~300.0 nmoL/L), the linear correlation coefficient R≥0.990.

 

 

 

 

 WWHS Assay list     
Cardiac     
cat#.Product itemSpecimenReaction TimeMeasure RangeClinical RangeItended Use
1cTnIWB/Serum/Plasma12min.0.1-40ng/ml<0.3ng/mlseveral heart diseases including myocardial infarction and heart failure.
2MyoWB/Serum/Plasma12min.5-400ng/ml<58ng/mlacute myocardial infarction (AMI) in early stage.
3CK-MBWB/Serum/Plasma12min.1-200ng/ml<5ng/mlacute myocardial infarction (AMI) in early stage.
4NT-proBNPWB/Serum/Plasma10min.20-35000pg/mlUnder 75:0~347pg/mL,
Over 75:0~449pg/mL
heart failure .
5D-DimerWB/Plasma10min.40-10000ng/ml<500ng/mldisseminated intravascular coagulation (DIC),deep vein thrombosis (DVT),pulmonary embolism (PE), myocardial infarction, cerebral infarction, etc.
6cTnI+Myo+CKMBWB/Serum/Plasma12min.same with single itemsame with single itemTriple marker of myocardial infarction.
7ST2WB/Serum/Plasma10min.10-400ng/ml<35ng/mlheart failure .
8Lp-PLA2WB/Serum/Plasma10min.10-900ng/ml<175ng/mlRisk evaluation of ACS and atherosclerotic ischemic stroke patients.
9S100-βWB/Serum/Plasma10min.0.05-10ng/ml<0.2ng/mlCerebral infarction, cerebral injury.
Inflammation     
10CRP / hs-CRPWB/Serum/Plasma3min.0.5-200mg/LCRP<10mg/L,hs-CRP<1mg/Lnonspecficity inflammatory marker.
11SAASerum5min.1-200mg/L<10mg/Linflammation&infection.
12PCTWB/Serum/Plasma10min.0.2-100ng/ml<0.5ng/mlSepsis
13CRP+SAAWB/Serum/Plasma5min.same with single itemsame with single iteminflammation&infection.
14IL-6WB/Serum/Plasma10min.5-4000pg/ml10pg/mldiabetes,rheumatoid arthritis,etc
Thyroid Hormone     
15TSHSerum/Plasma15min.0.3-100mU/L0.35-5mU/Lhyperthyroidism and hypothyroidism
16TT3Serum/Plasma15min.0.5-10nmol/L1.3-3.1nmol/Lthyroid dysfunction
17TT4Serum/Plasma15min.5-300nmol/L66-181nmol/Lthyroid dysfunction
18FT3Serum/Plasma15min.1-100pmol/L4-10pmol/Lthyroid dysfunction
19FT4Serum/Plasma15min.5-300pmol/L19-39pmol/Lthyroid dysfunction
Tumor Marker     
20AFPSerum/Plasma15min.2.5-200ng/ml<20ng/mlpregnancy cancer
21CEASerum/Plasma15min.1-200ng/ml<5ng/mlcolon cancer, colorectal cancer,etc.
22NSESerum/Plasma15min.1-400ng/ml<16ng/mlnon-small cell lung cancer
23FOBfecal specimens10min.50-1000ng/ml<100ng/mlAbnormal recessive gastrointestinal bleeding
24PG IISerum/Plasma15min.1-100ug/LPGI/PGII>3.0gastric abnormalities
25PG ISerum/Plasma15min.2.5-200ug/L>70ng/mlgastric abnormalities
26TPSASerum/Plasma15min.0.5-40ng/ml<4ng/mlprostate cancer
27FPSASerum/Plasma15min.0.1-10ng/ml<1ng/mlprostate cancer
28CA12-5Serum/Plasma15min.20-500U/ml<35U/mlovarian cancer
29CA15-3Serum/Plasma15min.10-400U/ml< 25 U/mLbreast cancer
30HE4Serum/Plasma15min.50-2000pmol/L<140 pmol/Lovarian cancer
31CA19-9Serum/Plasma15min.10-400U/ml< 27 U/mLpancreatic cancer
32β-HCGSerum/Plasma15min.5-400mIU/ml<10 mIU/mLEarly pregrancy, ectopic HCG cancer,incomplete abortion
33CK19(Cyfra21-1)Serum/Plasma15min.0.5-50ng/ml<2.5ng/mlnon-small cell lung cancer
Fertility     
34HCG / β-HCGSerum/Plasma10min.5-20000mIU/ml<5 mIU/mLearly pregrancy.
35AMHSerum/Plasma10min.0.1-16ng/mlMale: 20-60 years old, 0.92-13.89 ng/mL
Female: 20-29 years old, 0.88-10.35 ng/mL
30-39 years old, 0.31-7.86 ng/mL 40 -50 years old, <5. 07 ng/mL
ovarian reserve level
Gastrointestinal      
36FOBfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
37TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
38FOB+TRFfecal specimens10min.qualitativequalitativegastrointestinal hemorrhage.
Infection      
39C.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeCP infection
40M.PneumoniaWB/Serum/Plasma15min.qualitativequalitativeMP infection
41Covid-19 Antigennasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
42Covid-19 Ab IgG/IgMWB/Serum/Plasma15min.qualitativequalitativerespiratory tract
43FluAnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
44FluBnasal swab, throat swab or nasal wash/aspirate specimens15min.qualitativequalitativerespiratory tract
Renal Injury      
45CysCWB/Serum/Plasma5min.0.4-9mg/L0.5-1.1mg/Lrenal function
46NGALUrine10min.10-1500ng/mL<132ng/mLacute kidney injury.
Other      
47FERRSerum5min.10-500ng/mlMale:24ng/mL~335ng/mL,
Female:11ng/mL~307ng/mL
iron metabolism related diseases, such as hemochromatosis and iron deficiency anemia
48HbA1cWB10min.4%-14%4%-6%diabetes
49VDSerum/Plasma15min.8-70ng/mL19-57ng/mLfetation

 

 

 

Hot Products

【Product name】D-Dimer.pdf D-Dimer Rapid Quantitative Test(Fluorescence immunoassay) 【Main components...
【Product name】D-Dimer.pdf D-Dimer Rapid Quantitative Test(Fluorescence immunoassay) 【Inspection ...
【Product name】LP.pdf Diagnostic Kit for Lipoprotein-Associated Phospholipase A2(Immunochromatographi...
CTnI Cardiac Troponin I Test Kit WWHS FIA POCT(Fluorescence Immunoassay) [Product Name] Diagnostic ...
Myo Rapid Quantitative Test Kit WWHS FIA POCT Fluorescence Immunoassay 【Product Name 】 Myoglobin ...
CK-MB Rapid Quantitative Test Kit WWHS FIA POCT Fluorescence Immunoassay 【Product name】 Creatine ...